Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.80% Nasdaq Up0.97%

Galena Biopharma, Inc. (GALE)

-NasdaqCM

2.43 Down 0.07(2.80%) May 17, 4:00PM EDT|After Hours : 2.44 Up 0.01 (0.41%) May 17, 7:59PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue -   -   -  
Cost of Revenue -   -   -  
Gross Profit -   -   -  
Operating Expenses
Research Development14,034  3,712  6,046  
Selling General and Administrative7,165  8,774  10,579  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (21,199) (12,486) (16,625)
Income from Continuing Operations
Total Other Income/Expenses Net(13,178)9,079  4,632  
Earnings Before Interest And Taxes(34,377)(3,407)(11,993)
Interest Expense -   -   -  
Income Before Tax(34,377)(3,407)(11,993)
Income Tax Expense(1,052) -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(33,325)(3,407)(11,993)
Non-recurring Events
Discontinued Operations(1,644)(8,078) -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (34,969) (11,485) (11,993)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (34,969) (11,485) (11,993)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.